Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Lam Research
LRCX
$392B
| $5.61M | 0.01% |
411,740
-2,422,000
| -85% | -$34.7M |
|
1502
PTC Therapeutics
PTCT
$6.12B
| $5.61M | 0.01% |
163,311
-184,434
| -53% | -$6.63M |
|
1503
Grand Canyon Education
LOPE
$3.89B
| $5.6M | 0.01% |
58,277
-153,951
| -73% | -$17.9M |
|
|
FSCT
1504
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $5.58M | 0.01% |
214,634
+103,189
| +93% | +$2.86M |
|
|
REGI
1505
DELISTED
Renewable Energy Group, Inc.
REGI
| $5.57M | 0.01% |
216,898
-205,287
| -49% | -$5.55M |
|
1506
Invesco QQQ Trust
QQQ
$485B
| $5.57M | 0.01% |
36,129
-74,603
| -67% | -$12.5M |
|
|
ITG
1507
DELISTED
Investment Technology Group Inc
ITG
| $5.57M | 0.01% |
184,165
+62,931
| +52% | +$1.8M |
|
1508
BCE
BCE
$21.9B
| $5.57M | 0.01% |
140,821
-404,555
| -74% | -$16.6M |
|
|
WBK
1509
DELISTED
Westpac Banking Corporation
WBK
| $5.57M | 0.01% |
+318,666
| New | +$5.92M |
|
1510
CALL
Expedia Group
EXPE
$40.4B
| $5.57M | 0.01% |
49,400
+41,600
| +533% | +$4.98M |
|
1511
PUT
Trane Technologies
TT
$101B
| $5.57M | 0.01% |
+61,000
| New | +$6M |
|
|
LM
1512
DELISTED
Legg Mason, Inc.
LM
| $5.54M | 0.01% |
217,102
-177,892
| -45% | -$4.98M |
|
1513
Sensata Technologies
ST
$6.17B
| $5.52M | 0.01% |
123,143
+71,867
| +140% | +$3.25M |
|
1514
Texas Roadhouse
TXRH
$13.4B
| $5.51M | 0.01% |
92,367
+35,188
| +62% | +$2.26M |
|
1515
BOK Financial
BOKF
$8.5B
| $5.5M | 0.01% |
74,930
+71,230
| +1,925% | +$6.04M |
|
|
SCG
1516
CALL
DELISTED
Scana
SCG
| $5.5M | 0.01% |
+115,000
| New | +$4.94M |
|
|
SCG
1517
PUT
DELISTED
Scana
SCG
| $5.5M | 0.01% |
+115,000
| New | +$4.94M |
|
|
KNL
1518
DELISTED
Knoll, Inc.
KNL
| $5.49M | 0.01% |
333,336
+139,144
| +72% | +$2.72M |
|
1519
CALL
Stryker
SYK
$127B
| $5.49M | 0.01% |
35,000
+5,000
| +17% | +$836K |
|
1520
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15B
| $5.48M | 0.01% |
107,948
+92,448
| +596% | +$5.02M |
|
1521
PUT
T-Mobile US
TMUS
$193B
| $5.46M | 0.01% |
+85,900
| New | +$5.76M |
|
1522
Aldeyra Therapeutics
ALDX
$94.1M
| $5.46M | 0.01% |
657,976
-289,249
| -31% | -$2.96M |
|
|
NAVG
1523
DELISTED
Navigators Group Inc
NAVG
| $5.45M | 0.01% |
78,425
-187,455
| -71% | -$13M |
|
|
IMGN
1524
CALL
DELISTED
Immunogen Inc
IMGN
| $5.43M | 0.01% |
+1,131,100
| New | +$6.86M |
|
1525
Pediatrix Medical
MD
$2.18B
| $5.43M | 0.01% |
164,481
-986,332
| -86% | -$39.7M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.